GFAP and COVID-19: As far as we know, this is the first study to describe, simultaneously, the multisystemic and multiple biochemical parameters between survival and not survival severe COVID-19 patients associated to nervous system biomarkers NfL, GFAP, UCH-L1, and TAU.